The pathogenesis of diabetic retinopathy

Australian and New Zealand Journal of Ophthalmology

Volumn 24, Issue 2, 1996, Pages 97-104

  Larkins, R G ^a   Dunlop, M E ^a   Johnson, E I M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; DIACYLGLYCEROL; PROTEIN KINASE C; ADVANCED GLYCATION END PRODUCT;

ANGIOGENESIS; DIABETIC RETINOPATHY; HUMAN; SHORT SURVEY; ANIMAL; ARTICLE; BLOOD; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA;

ALDEHYDE REDUCTASE; ANIMALS; BLOOD GLUCOSE; DIABETIC RETINOPATHY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; RETINA;

EID: 0030132563     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1996.tb01561.x     Document Type: Short Survey

References (23)

1. Constable IJ, Cooper RL, Welborn TA, McCann VJ, Stanton KM, Knuiman M. Community screening for diabetic retinopathy. In: Hendkind P, ed. Acta: XXIV International Congress of Ophthalmology. Philadelphia: Lippincott, 1983;1332-5.
2. Mitchell P, Moffitt P. Update and implications from the Newcastle diabetic retinopathy study. Aust NZ J Ophthalmol 1990;18:13-17.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Larkins RG, Dunlop ME. The link between hyperglycaemia and diabetic retinopathy. Diabetologia 1992;35:499-504.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
6. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994;124:19-30.
7. Gabbay KH. The sorbitol pathway and the complications of diabetes. N Engl J Med 1973;288: 831-6.
8. Kador PF. Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 1995;113:352-4.
9. Frank RN. The aldose reductase controversy. Diabetes 1994;43:169-72.
10. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606.
11. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993;42:801-13.
12. Craven PA, Davidson CM, De Rubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990;39:667-74.
13. Wolf BA,Williamson JR, Eason RA, Chang K, Sherman WR, Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991;87:31-8.
14. Chang WP, Dimitriadis E, AllenT, Dunlop ME, Cooper M, Larkins RG. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 1991;34:225-31.
15. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 1993;265:E783-93.
16. Mahadevan P, Larkins RG, Fraser JRE, Fosang AJ, Dunlop M. Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan synthesis. Diabetologia 1995;38:298-305.
17. Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J. Insulin-like growth factor 1 acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 1993;36:282-91.
18. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92:905-9.
19. 3 for angiogenesis. Science 1994;264:569-71.
20. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes. Lancet 1983;1:200-4.
21. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med 1984;11:365-72.
22. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose, control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: the Oslo study. BMJ 1985;290:811-15.
23. Sutherland DE. Effect of pancreas transplants on secondary complications of diabetes: review of observations at a single institution. Transplant Proc 1992;24:859-60.